Nuwellis Inc Market Cap ($2.46 Million)
Market Cap & Net Worth: Nuwellis Inc (NUWE)
Nuwellis Inc market cap. Nuwellis Inc (NASDAQ:NUWE) has a market capitalization of $2.46 Million ($2.46 Million) as of November 4, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #29771 globally and #6085 in its home market, demonstrating a 1617.52% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Nuwellis Inc's stock price $5.91 by its total outstanding shares 3647264 (3.65 Million). Also see Nuwellis Inc cash flow conversion for how efficiently the company converts equity into cash flow.
Nuwellis Inc Market Cap History (2015–2026)
Nuwellis Inc market cap history from 2015 to 2026. Data shows change from $3.65 Trillion to $21.56 Million (-66.36% CAGR). Check Nuwellis Inc (NUWE) share price today for real-time trading data and today's change.
Index Memberships
Nuwellis Inc is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.61 Trillion | 0.00% | #857 of 976 |
|
NASDAQ Composite
IXIC
|
$40.20 Trillion | 0.00% | #2752 of 3165 |
Weight: Nuwellis Inc's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Nuwellis Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Nuwellis Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore Nuwellis Inc net asset momentum to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
0.77x
Nuwellis Inc's market cap is 0.77 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $3.65 Trillion | $1.29 Million | -$15.79 Million | 2829529.87x | N/A |
| 2017 | $3.65 Trillion | $3.55 Million | -$13.38 Million | 1026530.82x | N/A |
| 2018 | $2.62 Trillion | $5.00 Million | -$17.03 Million | 523703.67x | N/A |
| 2019 | $329.81 Billion | $5.51 Million | -$18.11 Million | 59845.30x | N/A |
| 2020 | $88.98 Billion | $7.44 Million | -$15.84 Million | 11957.40x | N/A |
| 2021 | $14.55 Billion | $7.92 Million | -$19.55 Million | 1837.22x | N/A |
| 2022 | $1.37 Billion | $8.54 Million | -$14.53 Million | 160.18x | N/A |
| 2023 | $74.15 Million | $8.86 Million | -$20.21 Million | 8.37x | N/A |
| 2024 | $4.05 Million | $8.74 Million | -$11.16 Million | 0.46x | N/A |
| 2025 | $6.35 Million | $8.27 Million | -$17.52 Million | 0.77x | N/A |
Competitor Companies of NUWE by Market Capitalization
Companies near Nuwellis Inc in the global market cap rankings as of November 4, 2026. Also see Nuwellis Inc balance sheet assets for a full breakdown of the balance sheet.
Key companies related to Nuwellis Inc by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #110 globally with a market cap of $190.23 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #204 globally with a market cap of $119.12 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #226 globally with a market cap of $109.30 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #239 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #110 | Abbott Laboratories | NYSE:ABT | $190.23 Billion | $109.40 |
| #204 | Stryker Corporation | NYSE:SYK | $119.12 Billion | $310.55 |
| #226 | Medtronic PLC | NYSE:MDT | $109.30 Billion | $98.88 |
| #239 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
Market Capitalization of Nuwellis Inc (2015–2026)
Market capitalization of Nuwellis Inc from 2015 to today. Between 2015 and today, Nuwellis Inc's market cap moved from $3.65 Trillion to $ 21.56 Million, with a yearly change of -66.36%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $21.56 Million | +239.66% |
| 2025 | $6.35 Million | +56.76% |
| 2024 | $4.05 Million | -94.54% |
| 2023 | $74.15 Million | -94.58% |
| 2022 | $1.37 Billion | -90.60% |
| 2021 | $14.55 Billion | -83.64% |
| 2020 | $88.98 Billion | -73.02% |
| 2019 | $329.81 Billion | -87.40% |
| 2018 | $2.62 Trillion | -28.23% |
| 2017 | $3.65 Trillion | 0.00% |
| 2016 | $3.65 Trillion | 0.00% |
| 2015 | $3.65 Trillion | -- |
End of Day Market Cap According to Different Sources
On Nov 4th, 2026 the market cap of Nuwellis Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $2.46 Million USD |
| MoneyControl | $2.46 Million USD |
| MarketWatch | $2.46 Million USD |
| marketcap.company | $2.46 Million USD |
| Reuters | $2.46 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Nuwellis Inc
Nuwellis, Inc., a medical device company, develops, manufactures, and commercializes medical devices used in ultrafiltration therapy. The company provides Aquadex FlexFlow and Aquadex SmartFlow systems, which are used to treat patients suffering from fluid overload due to heart failure, as well as Aquadex SmartFlow system for temporary use in adult and pediatric patients. The company was formerly… Read more